Pharma Capital
Showing 9 of 9
Name Market Market Cap Share Price Daily Share Movement
ahz[LOGO]200x100.jpg Admedus Ltd ASX £40.29m £0.16 1.96% ico_glass.png
cdy[LOGO]200x100.jpg Cellmid Ltd ASX £15.65m £0.01 -7.69% ico_glass.png
Cynata.png Cynata Therapeutics ASX £34.50m £0.38 2.44% ico_glass.png
au_novogen__120x60.jpg Novogen ASX £12.05m £0.02 -16.33% ico_glass.png
par[LOGO]200x100.jpg Paradigm Biopharmaceuticals Ltd ASX £17.67m £0.17 -1.72% ico_glass.png
Pharmaxis---200x100.jpg Pharmaxis Ltd ASX £49.52m £0.16 0.00% ico_glass.png
au_piqlogo_new120x60.jpg Proteomics International Laboratories ASX £6.46m £0.11 -10.00% ico_glass.png
rgs[LOGO]200x100.jpg Regeneus Ltd ASX £13.97m £0.07 -8.33% ico_glass.png
thc[LOGO]200x100.jpg The Hydroponics Company Ltd ASX £21.44m £0.16 0.00% ico_glass.png

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.